Immune-related genes that could serve as potential therapeutic targets for pulmonary arterial hypertension (PAH) were identified in a recent…
Articles by Lindsey Shapiro, PhD
An inhaled formulation of imatinib in development by Aerami Therapeutics to treat pulmonary arterial hypertension (PAH), was safe…
Scientists have identified gene, protein, and signaling pathway alterations in the livers of people with portopulmonary hypertension (PoPH) — a…
Among patients undergoing surgery for a heart valve disease, the presence of pulmonary hypertension (PH) was associated with a…
Certain proteins implicated in the immune response and inflammation showed a potential to serve as blood biomarkers of pulmonary…
Scientists in India have developed derivatives of bosentan — the active ingredient in Tracleer — that were able to…
People with a combination of two lung diseases — specifically pulmonary fibrosis and emphysema, known as CPFE — who also…
A one-time surgical procedure called pulmonary artery denervation or PADN was linked to a reduced risk of clinical worsening in…
Treatment with cannabidiol (CBD) for three weeks lowered signs of cardiac fibrosis, or scar tissue build-up, in a rat model…
AV-101, an inhaled formulation of imatinib for people with pulmonary arterial hypertension (PAH) now being tested in clinical trials,…
A gene called RASA3 may be a candidate gene — one suspected of playing a role in a specific trait…
Noninvasive clinical assessments to identify children with pulmonary arterial hypertension (PAH) at risk of poorer outcomes align well with…